WO2008054426A1 - Nutritional supplement - Google Patents
Nutritional supplement Download PDFInfo
- Publication number
- WO2008054426A1 WO2008054426A1 PCT/US2006/060540 US2006060540W WO2008054426A1 WO 2008054426 A1 WO2008054426 A1 WO 2008054426A1 US 2006060540 W US2006060540 W US 2006060540W WO 2008054426 A1 WO2008054426 A1 WO 2008054426A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- additive
- supplement
- albumin
- nutritional supplement
- additive comprises
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K40/00—Shaping or working-up of animal feeding-stuffs
- A23K40/30—Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
Definitions
- the present invention relates to a nutritional supplement including an albumin carrier for an additive.
- the nutritional supplement may be dispersed on or into, e.g., an animal or bird food substrate.
- An aspect of the present invention relates to a nutritional supplement comprising albumin and an additive combined with the albumin. Another aspect relates to providing a nutritional supplement including albumin and an additive and combining the nutritional supplement with a resin composition. The resin composition and nutritional supplement may then be formed into a desired shape.
- the present invention relates to a nutritional supplement including an albumin carrier for additives.
- the albumin may be coated on or combined with a bird or animal food substrate.
- a food substrate is a reference to, e.g., feed, seed, food, chews or treats.
- the nutritional supplement may include additives such as flavorants, attractants, minerals, vitamins, herbs, fatty acids, fermented soy nutraceutical, yeast products enzymes/coenzymes and other products.
- Albumin may be understood herein to be any heat-coagulable water-soluble protein that may occur in blood plasma or serum, muscle, the whites of eggs, milk, and other animal substances and in many plant tissues and fluids. Accordingly, the albumin may be used to increase protein content and, in some instances, may include little to no fat content.
- the albumin may be provided in either powdered or liquid form. The albumin may be present between 1-99% of the nutritional supplement and all increments and values therein.
- meal it is meant to include the clean, dried, ground or rendered tissue of undecomposed animal or fish.
- digests it is meant to include a substance made by taking relatively clean and relatively undecomposed animal tissue and breaking it down utilizing chemical or enzymatic hydrolysis.
- the animal digest may be hydrolyzed liver, e.g., hydrolyzed beef or poultry liver.
- the animal meal or digests may not contain hair, horn, teeth, hooves or feathers, which may be present in unavoidable trace amounts.
- Animal digests may be obtained from Applied Food Biotechnology Incorporated, O'Fallon, Missouri, and sold under the trade name Optimizor®.
- Fruit matter, vegetable matter, nuts, nut bits, nut flour, etc. may also be incorporated as a flavorant and/or an attractant.
- the flavorants and/or attractants may be incorporated into the nutritional supplement individually or in combination between 0.1-50% by weight and any incremental value or ranges therebetween.
- Fermented soy nutraceutical and/or enzymes and coenzymes may also be incorporated into the albumin.
- the fermented soy nutraceutical may be incorporated into the nutritional supplement between 0.01-50% by weight and any incremental value or range there between.
- Fermented soya nutraceuticals are available from Bio Food, Ltd., Pine Brook, NJ. and sold under the general trademark Soynatto®.
- Soynatto® product is more specifically described to contain the following as compared to other available compositions:
- the Soynatto® product may provide proteins, minerals, and vitamins, in a fermented soy form.
- the fermentation process may infuse the product with saccharomyces cerevisiae, commonly known as "bakers yeast” or “brewers yeast.” Saccharomyces cerevisiae is more traditionally known to ferment sugars present in flour or dough, yielding carbon dioxide and alcohol. Accordingly, it should be appreciated that a protein, one or more of a mineral, and one or more of a vitamin, along with saccharomyces cerevisiae may be present in the nutritional supplement.
- the fermented soy product herein may include increased concentrations of glycitein, daidzein and genistein, reportedly present at several hundred percent more than other more common soyfood sources.
- Glycitein, daidzein and genistein belong to the isofavone class of flavanoids and may be classified as phytoestrogen, since they are plant derived nonsteriodal compounds that contain estrogen-like biological activity.
- An enzyme and/or co-enzyme which are similarly available through Bio Foods, Ltd., Pine Brook, NJ. and sold under the trademark of BT-CoQIO® may also be included in the nutritional supplement.
- This reportedly is a biologically transformed (fermented) cell mitochondrial coenzyme and contains Coenzyme QlO, antioxidants, phytonetrients and cof actor mineral nutrients and other cell constituents.
- the enzymes and/or co-enzymes may be incorporated into the albumin between 0.01-10% by weight and any incremental value or range therebetween.
- the coenzyme QlO is a fat-soluble compound primarily synthesized by the body and also consumed in the diet and is required for mitochondrial ATP synthesis.
- the fermented coenzyme also reportedly belongs to the family of compounds known as ubiquinones, which are either of two isomeric cyclic crystalline compounds CgH 4 O 2 that are di-keto derivatives of dihydro-benzene. It may also function as an antioxidant in cell membranes and lipoproteins.
- a yeast product may also be incorporated into the nutritional supplement and may include for example, nutritional yeast or brewers yeast such as saccharomyces cerevisiae, dairy yeast such as kluyveromyce marxianus or wine yeast such as saccharomyces fermentati.
- the yeast may be in a powdered, flake or tablet form prior to addition to the albumin.
- the brewers yeast, or saccharomyces cerevisiae, are believed rich in B -complex vitamins and other nutrients.
- the yeast products may be incorporated into the nutritional supplement between 0.1-10% by weight and any incremental value or range therebetween.
- Vitamins that may be incorporated into the nutritional supplement may include A, C, B 6 , Bi 2 , D, E and K, thiamine, riboflavin, pantothenic acid, niacin, inositol, pyridoxine, folic acid, biotin, choline and para-aminobenzoic acid (PABA).
- Minerals that may be incorporated into the albumin may include calcium, calcium carbonate, calcium chloride, dicalcium phosphate, iron carbonate, phosphorus, potassium, potassium chloride, sodium, sodium selenite, sodium molybdate, chloride, magnesium, magnesium oxide, iron, copper, copper oxide, manganese, zinc, zinc oxide, iodine and selenium.
- the herbs herein may be selected from the group consisting of St. John's Wort, kava kava, ginkgo biloba, ginseng (Asian or Siberian varieties), echinacea and mixtures thereof.
- Other herbs include catsclaw, chamomile, goldenseal, saw palmetto, valerian, vitex agnus-castus, black cohosh, bilberry and milk thistle.
- Herbs may also include aloe, astragalus, burdock, chestnut, chlorophyll, coriolus versicolor, couch grass, crampbark, dandelion root, dong quai, elecampane, evening primrose, eyebright, false unicorn root, feverfew, garlic, ginger, gota kola, grape seed extract, green tea, gugulipid, hawthorn, hops, ivy, licorice, milk thistle, mint, mistletoe (American Asian and European varieties), motherwort, oats, osha, passion flower, parsley, pumpkin, pygeum, red clover, rosemary, sarsparilla, skullcap, stinging nettle, wild indigo, wild yam and yerba mansa.
- glucosamines and/or chondroitin can be added to any of the embodiments described herein. It should also be appreciated that the extracts and derivatives of herbs may be employed as well.
- omega fatty acids may be incorporated into the nutritional supplement as well. These omega fatty acids may include omega-3 and/or omega-6 fatty acids.
- vitamins, minerals, herbs and fatty acids may be incorporated into the nutritional supplement at or below recommended daily maximum doses which may vary for the individual vitamin, herb, mineral or fatty acid contemplated, depending on the intended recipient, i.e. bird, animal, etc.
- the nutritional supplement may be supplied in powdered form or liquid form. When supplied in powdered form, the supplement may be reconstituted using appropriate amounts of water.
- the supplement, or individual components of the supplement, such as the albumin, may also be pasteurized.
- the nutritional supplement may be added as a sauce or coating on food substrate, including, for example, bird feed, dog food or cat food.
- the supplement may be applied by the manufacturer, supplier or consumer to the food, chew or treat.
- the nutritional supplement may be added into animal food, chews or treats.
- the nutritional supplement may act as a carrier for the additives and be dispersed in a resin.
- the resin may be a starch, polymeric, casein, gluten, comminuted rawhide, collagen or animal protein.
- Gluten may be a water-insoluble protein complex extracted from cereal grains and may include corn or wheat gluten.
- the resin may be combined with water and formed into a desired shape.
- the resin may be present between about 60-99% and any incremental value or range therebetween and the nutritional supplement may be present between about 1-40% and any incremental value or range therebetween. It should be appreciated however, that greater amounts of the nutritional supplement may be present as well, such as up to 60%.
- the nutritional supplement may be incorporated into the resin during any compounding step including, melt mixing, extrusion or injection molding, or post molding in either powdered or liquid form. It should be appreciated however, that it may be necessary to temper the albumin prior to adding the albumin directly to a hot substance, such as a liquid, i.e. water or digest, or a resin composition that is greater than approximately 60 degrees C. By tempering it is meant that the albumin in the nutritional supplement may be warmed slowly so as to prevent the albumin from curdling.
- the nutritional supplement may be incorporated into a starch resin.
- the starch may include any carbohydrate of natural or vegetable origin.
- the starch may include amylose and/or amylopectin and may be extracted from plants, including but not limited to potatoes, rice, tapioca, corn and cereals such as rye, wheat, and oats.
- the starch may be present in the resin between about 30-99% including all increments and values therebetween such as levels above about 50%, 85%, etc.
- the starch employed herein may be raw starch, which may be understood as starch that has not seen a prior thermal molding history, such as extrusion or other type of melt processing step.
- the raw starch itself may also be native, which may be understood as unmodified starch recovered in the original form by extraction and not physically or chemically modified.
- the raw starch may also be in powder form of varying particle size, which may be understood as milled and/or pre-sifted. It should be understood that the raw starch may also have varying degrees of moisture present.
- the resin may include cellulose.
- the cellulose may be, for example, a long-chain polymer of polysaccharide carbohydrate.
- the cellulose may also be derived or extracted from plants.
- the cellulose may be incorporated into the resin between about 1-15% by weight of the resin and any increment or value therebetween including 4%, 10%, 11%, etc.
- Emulsifiers or surfactants may also be incorporated into the resin.
- the emulsifier may be present between about 1-10% by weight of the resin and all increments or values therebetween including 3%, 4%, etc.
- the emulsifier may include, for example, lecithin, which may be extracted or derived from, for example, egg yolk or soy beans.
- the resin may also include a plasticizer.
- the plasticizer may include for example, glycerin.
- the plasticizer may be incorporated between about 15-30%, including all increments and values therebetween such as levels greater than 15%, 21%, 27% etc.
- a humectant may also be incorporated into the resin.
- the humectant may include, for example, oat fiber.
- the humectant may be incorporated between about 0.1-5% by weight of the resin including all intervals and values therebetween, including 1%, 25%, etc.
- a humectant may be understood to be any additive that may absorb water in the material.
- Water may also be combined with the resin. The water may be introduced into the resin between about 1-40% by weight of the resin and any increment or value therebetween, including 4%, 20-40%, 10-20%, etc. After the product has been formed, the water may be present between 1-20% by weight of the resin including all increments or values therebetween, such as, below 20%, 4%, 5-10%, etc.
- the resin, nutritional supplement and water may be introduced into an extruder.
- the extruder may be either a twin screw or single screw extruder.
- the water may be introduced between 20-40% by weight.
- the water may be vented from the extruder to reduce the amount of water present in the extrudate resin composition. Accordingly, the extruder may be provided with a vented barrel including vent ports.
- the extrudate resin composition may then be cooled and/or pelletized.
- This composition may then be injection molded and formed into a desired shape.
- the water present in the resin may be reduced to at or below 20% and any incremental value or range between l%-20%.
- the injection molding machine barrel and/or mold may be vented as well.
- the nutritional supplement may be added to the resin during the injection molding step as an alternative or in combination with adding the nutritional supplement to the resin during extrusion.
- the resin, water and nutritional supplement may be combined and formed during the injection molding process without previously extruding the resin. Accordingly, the resin, water and nutritional supplement may be added directly into the barrel of an injection molding machine where it is combined and formed into a desired shape.
- the water may be added to the injection molding machine between 20-40% by weight and reduced to at or below 20% and any incremental value or range between l%-20%.
- the barrel and/or the mold may be vented.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Husbandry (AREA)
- Birds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Fodder In General (AREA)
Abstract
Description
Claims
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06846230.8A EP2086355B1 (en) | 2006-11-03 | 2006-11-03 | Nutritional supplement |
AU2006350215A AU2006350215B2 (en) | 2006-11-03 | 2006-11-03 | Nutritional supplement |
CNA2006800564703A CN101605467A (en) | 2006-11-03 | 2006-11-03 | Nutritious supplementary pharmaceutical |
JP2009535251A JP2010508812A (en) | 2006-11-03 | 2006-11-03 | Nutritional supplement |
PCT/US2006/060540 WO2008054426A1 (en) | 2006-11-03 | 2006-11-03 | Nutritional supplement |
CA2668326A CA2668326C (en) | 2006-11-03 | 2006-11-03 | Nutritional supplement |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2006/060540 WO2008054426A1 (en) | 2006-11-03 | 2006-11-03 | Nutritional supplement |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2008054426A1 true WO2008054426A1 (en) | 2008-05-08 |
Family
ID=39344580
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2006/060540 WO2008054426A1 (en) | 2006-11-03 | 2006-11-03 | Nutritional supplement |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP2086355B1 (en) |
JP (1) | JP2010508812A (en) |
CN (1) | CN101605467A (en) |
AU (1) | AU2006350215B2 (en) |
CA (1) | CA2668326C (en) |
WO (1) | WO2008054426A1 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8836345B2 (en) | 2007-11-05 | 2014-09-16 | Impedimed Limited | Impedance determination |
US9149235B2 (en) | 2004-06-18 | 2015-10-06 | Impedimed Limited | Oedema detection |
US9392947B2 (en) | 2008-02-15 | 2016-07-19 | Impedimed Limited | Blood flow assessment of venous insufficiency |
US9585593B2 (en) | 2009-11-18 | 2017-03-07 | Chung Shing Fan | Signal distribution for patient-electrode measurements |
US9615767B2 (en) | 2009-10-26 | 2017-04-11 | Impedimed Limited | Fluid level indicator determination |
US11660013B2 (en) | 2005-07-01 | 2023-05-30 | Impedimed Limited | Monitoring system |
US11737678B2 (en) | 2005-07-01 | 2023-08-29 | Impedimed Limited | Monitoring system |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6061270B2 (en) * | 2010-08-30 | 2017-01-18 | 学校法人日本大学 | Hypoglycemic agent and health food containing rice albumin |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3962462A (en) * | 1974-05-31 | 1976-06-08 | The Quaker Oats Company | Stabilization of dry pet food |
US6254920B1 (en) * | 1998-11-24 | 2001-07-03 | Ralston Purina Company | Methods and compositions for enhancing palatability of pet food |
US20030104102A1 (en) * | 2001-11-13 | 2003-06-05 | Nelles Lynn P. | Treatment of vegetable oils or animal fats with sulfur or nitrogen donor compounds for animal food flavorings |
US6946488B2 (en) * | 2000-05-01 | 2005-09-20 | The Iams Company | Pet food composition for reducing inflammatory response in cats |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2134117B (en) * | 1983-01-21 | 1986-05-29 | British Food Manufacturing Ind | Protein composition |
JPH0616366B2 (en) * | 1988-06-28 | 1994-03-02 | 東京電力株式会社 | DC power cable |
US5543164A (en) * | 1994-06-17 | 1996-08-06 | The Regents Of The University Of California | Water-insoluble protein-based edible barrier coatings and films |
US5620735A (en) * | 1995-02-01 | 1997-04-15 | Cargill, Incorporated | Simulated egg patty |
US6379725B1 (en) * | 1998-05-05 | 2002-04-30 | Natural Polymer International Corporation | Protein-based chewable pet toy |
US20060141099A1 (en) * | 2002-07-18 | 2006-06-29 | Hudson Margaret F | Scrambled egg snack food |
EP1388297A1 (en) * | 2002-08-06 | 2004-02-11 | Nestec S.A. | Calcium absorption enhancer |
ES2306079T3 (en) * | 2004-01-30 | 2008-11-01 | Basf Se | GRANULATES CONTAINING STABILIZING FITASA FORMULATIONS. |
JP2006006108A (en) * | 2004-06-22 | 2006-01-12 | Asahi Denka Kogyo Kk | Water-in-oil emulsified oil and fat composition |
-
2006
- 2006-11-03 JP JP2009535251A patent/JP2010508812A/en active Pending
- 2006-11-03 WO PCT/US2006/060540 patent/WO2008054426A1/en active Application Filing
- 2006-11-03 CN CNA2006800564703A patent/CN101605467A/en active Pending
- 2006-11-03 EP EP06846230.8A patent/EP2086355B1/en active Active
- 2006-11-03 CA CA2668326A patent/CA2668326C/en active Active
- 2006-11-03 AU AU2006350215A patent/AU2006350215B2/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3962462A (en) * | 1974-05-31 | 1976-06-08 | The Quaker Oats Company | Stabilization of dry pet food |
US6254920B1 (en) * | 1998-11-24 | 2001-07-03 | Ralston Purina Company | Methods and compositions for enhancing palatability of pet food |
US6946488B2 (en) * | 2000-05-01 | 2005-09-20 | The Iams Company | Pet food composition for reducing inflammatory response in cats |
US20030104102A1 (en) * | 2001-11-13 | 2003-06-05 | Nelles Lynn P. | Treatment of vegetable oils or animal fats with sulfur or nitrogen donor compounds for animal food flavorings |
Non-Patent Citations (1)
Title |
---|
See also references of EP2086355A4 * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9149235B2 (en) | 2004-06-18 | 2015-10-06 | Impedimed Limited | Oedema detection |
US11660013B2 (en) | 2005-07-01 | 2023-05-30 | Impedimed Limited | Monitoring system |
US11737678B2 (en) | 2005-07-01 | 2023-08-29 | Impedimed Limited | Monitoring system |
US8836345B2 (en) | 2007-11-05 | 2014-09-16 | Impedimed Limited | Impedance determination |
US9392947B2 (en) | 2008-02-15 | 2016-07-19 | Impedimed Limited | Blood flow assessment of venous insufficiency |
US9615767B2 (en) | 2009-10-26 | 2017-04-11 | Impedimed Limited | Fluid level indicator determination |
US9585593B2 (en) | 2009-11-18 | 2017-03-07 | Chung Shing Fan | Signal distribution for patient-electrode measurements |
Also Published As
Publication number | Publication date |
---|---|
EP2086355A1 (en) | 2009-08-12 |
AU2006350215B2 (en) | 2012-04-26 |
AU2006350215A1 (en) | 2008-05-08 |
CA2668326A1 (en) | 2008-05-08 |
EP2086355B1 (en) | 2017-06-21 |
CA2668326C (en) | 2014-02-18 |
JP2010508812A (en) | 2010-03-25 |
CN101605467A (en) | 2009-12-16 |
EP2086355A4 (en) | 2010-06-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7691424B2 (en) | Nutritional supplement | |
CA2668326C (en) | Nutritional supplement | |
EP1887854B1 (en) | Methods for enhancing palatability of compositions for animal consumption | |
US8916179B2 (en) | Ascophyllum nodosum animal chews | |
CN105682473B (en) | Dry pet food comprising a palatability enhancing coating | |
RU2392830C2 (en) | Method for reduction of fodder consumption and control of animal weight | |
KR20170081657A (en) | Palatable dry cat foods and methods for preparation thereof | |
ZA200604459B (en) | Palatability enhanced composition and method for animal consumption | |
KR20190014095A (en) | A method for producing a cat kibble having excellent palatability | |
US20050276881A1 (en) | Animal food palatability enhancer and method of use and manufacture thereof | |
AU2013341073B2 (en) | Use of protein hydrolysates and nucleotides for enhancing palatability of fish feed | |
US8182855B2 (en) | Fish food containing fermented soyfood | |
EA014382B1 (en) | Dry expansion extruded feed for domestic animals and method for production thereof | |
KR102595963B1 (en) | Functional feed composition containing creatine and octacosanol | |
Ljubojević et al. | The nutritive value of extruded corn in nutrition of broiler chickens | |
Aturamu et al. | Economic Analyses and the Growth Performance of Broiler Starter Birds on High Fibre-low Protein Industrial Plant By-products | |
US20230330050A1 (en) | Methods and Compositions for Diagnosis and Treatment of Disorders in Pets | |
JP2008199960A (en) | Dog food | |
Fatokun et al. | Haematological and serum biochemical indices of broiler chicks fed cooked and fermented shea butter Vitelleria paradoxa cake meal. | |
Anyaegbu et al. | EVALUATION OF HAEMATOLOGICAL INDICES OF FINISHER BROILER CHICKENS FED DIETS CONTAINING Calapogonium mucunoides LEAF MEAL SUPPLEMENTED WITH YEAST (Saccharomyces cerevisiae) | |
Popoola et al. | Utilization and Cost Benefit of Replacement of Maize with Bread Waste in the Diet of Weaned Rabbits | |
KR20240058703A (en) | Functionality cat feed and method for manufacturing the same. | |
Vasupen et al. | Digestibility of sun dried cassava chips in dogs. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200680056470.3 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 06846230 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006350215 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref document number: 2009535251 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2668326 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2006350215 Country of ref document: AU Date of ref document: 20061103 Kind code of ref document: A |
|
REEP | Request for entry into the european phase |
Ref document number: 2006846230 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006846230 Country of ref document: EP |